NO20053090L - Pulverformulering for innhalering inneholdende tiotropium. - Google Patents

Pulverformulering for innhalering inneholdende tiotropium.

Info

Publication number
NO20053090L
NO20053090L NO20053090A NO20053090A NO20053090L NO 20053090 L NO20053090 L NO 20053090L NO 20053090 A NO20053090 A NO 20053090A NO 20053090 A NO20053090 A NO 20053090A NO 20053090 L NO20053090 L NO 20053090L
Authority
NO
Norway
Prior art keywords
powder formulation
containing tiotropium
inhalation containing
inhalation
treatment
Prior art date
Application number
NO20053090A
Other languages
English (en)
Other versions
NO20053090D0 (no
Inventor
Michael Walz
Michael Trunk
Mareke Hartig-Heimel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053090(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20053090D0 publication Critical patent/NO20053090D0/no
Publication of NO20053090L publication Critical patent/NO20053090L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives tiotiopium-holdige pulverformede tilberedninger for inhalasjon, fremgangsmåter for fremstiUing av disse, samt deres anvendelse til fremstiUing av et legemiddel til behandling av luftveissykdommer, særhg til behandling av eOPD (chronic obstructive pulmonary disease = kronisk obstruktiv lungesykdom) og astma.
NO20053090A 2002-11-28 2005-06-23 Pulverformulering for innhalering inneholdende tiotropium. NO20053090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PCT/EP2003/012911 WO2004047796A2 (de) 2002-11-28 2003-11-19 Neue tiotropium-haltige pulverformulierung für die inhalation

Publications (2)

Publication Number Publication Date
NO20053090D0 NO20053090D0 (no) 2005-06-23
NO20053090L true NO20053090L (no) 2005-06-23

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053090A NO20053090L (no) 2002-11-28 2005-06-23 Pulverformulering for innhalering inneholdende tiotropium.

Country Status (34)

Country Link
EP (1) EP1567135B1 (no)
JP (1) JP4977321B2 (no)
KR (1) KR101066805B1 (no)
CN (1) CN100574751C (no)
AR (1) AR042242A1 (no)
AT (1) ATE401861T1 (no)
AU (1) AU2003294714B2 (no)
BR (1) BR0316343A (no)
CA (1) CA2507579C (no)
CO (1) CO5580736A2 (no)
CY (1) CY1108420T1 (no)
DE (2) DE10255387A1 (no)
DK (1) DK1567135T3 (no)
EA (1) EA011549B1 (no)
EC (1) ECSP055821A (no)
ES (1) ES2310681T3 (no)
HK (1) HK1085918A1 (no)
HR (1) HRP20050468A2 (no)
IL (1) IL168810A (no)
ME (1) MEP51608A (no)
MX (1) MXPA05005485A (no)
MY (1) MY140890A (no)
NO (1) NO20053090L (no)
PE (1) PE20040848A1 (no)
PL (1) PL376229A1 (no)
PT (1) PT1567135E (no)
RS (1) RS20050400A (no)
SA (1) SA04240467B1 (no)
SI (1) SI1567135T1 (no)
TW (1) TWI332837B (no)
UA (1) UA81930C2 (no)
UY (1) UY28096A1 (no)
WO (1) WO2004047796A2 (no)
ZA (1) ZA200502859B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
KR101805958B1 (ko) * 2010-08-03 2017-12-07 키에시 파르마슈티시 엣스. 피. 에이. 포스포디에스테라제 억제제를 포함하는 건조 분말 제제
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
AU757008B2 (en) * 2000-10-12 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel tiotropium-containing inhalation powder
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
ATE339951T1 (de) * 2002-04-04 2006-10-15 Boehringer Ingelheim Pharma Pulverzubereitungen zur inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
MY140890A (en) 2010-01-29
CA2507579A1 (en) 2004-06-10
PE20040848A1 (es) 2005-01-14
DE10255387A1 (de) 2004-06-09
ES2310681T3 (es) 2009-01-16
ZA200502859B (en) 2006-02-22
PL376229A1 (en) 2005-12-27
JP2006510622A (ja) 2006-03-30
EA011549B1 (ru) 2009-04-28
BR0316343A (pt) 2005-09-27
WO2004047796A3 (de) 2004-09-30
TWI332837B (en) 2010-11-11
JP4977321B2 (ja) 2012-07-18
HK1085918A1 (en) 2006-09-08
CN100574751C (zh) 2009-12-30
HRP20050468A2 (en) 2006-07-31
EA200500864A1 (ru) 2006-02-24
AR042242A1 (es) 2005-06-15
RS20050400A (en) 2007-04-10
KR101066805B1 (ko) 2011-09-22
ECSP055821A (es) 2005-08-11
KR20050086887A (ko) 2005-08-30
TW200500066A (en) 2005-01-01
ATE401861T1 (de) 2008-08-15
CN1717225A (zh) 2006-01-04
WO2004047796A2 (de) 2004-06-10
MEP51608A (en) 2011-02-10
PT1567135E (pt) 2008-09-01
SA04240467B1 (ar) 2008-10-15
NO20053090D0 (no) 2005-06-23
UA81930C2 (uk) 2008-02-25
DK1567135T3 (da) 2008-10-27
EP1567135B1 (de) 2008-07-23
CY1108420T1 (el) 2014-04-09
DE50310208D1 (de) 2008-09-04
AU2003294714B2 (en) 2009-10-08
CA2507579C (en) 2011-07-19
UY28096A1 (es) 2004-06-30
MXPA05005485A (es) 2005-07-25
CO5580736A2 (es) 2005-11-30
AU2003294714A1 (en) 2004-06-18
SI1567135T1 (sl) 2008-10-31
IL168810A (en) 2015-02-26
EP1567135A2 (de) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20053548L (no) Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat.
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
NO20053090L (no) Pulverformulering for innhalering inneholdende tiotropium.
MY155912A (en) New inhalable powder containing tiotropium
NO20061441L (no) Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
HRP20040752B1 (hr) Superfina formulacija formoterola
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
NO20051956L (no) Salmeterol superfin formulering
CY1114157T1 (el) Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
NO20073909L (no) Forstover-formulering
HK1078795A1 (en) Powder formulations suitable for inhalation
WO2005007134A8 (de) Pulverformulierungen für die inhalation enthaltend ein neues anticholinergikum

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application